Lv41
676 积分 2024-07-16 加入
AZD4320, A Dual Inhibitor of Bcl-2 and Bcl-xL, Induces Tumor Regression in Hematologic Cancer Models without Dose-limiting Thrombocytopenia
4小时前
已完结
Targeting PI3K/AKT/mTOR pathway to enhance the anti-leukemia efficacy of venetoclax
6小时前
已完结
Engineered Cell Membrane Vesicles Loaded with Lysosomophilic Drug for Acute Myeloid Leukemia Therapy via Organ-Cell-Organelle Cascade-Targeting
2个月前
已完结
Top advances of the year: Myeloproliferative neoplasms
4个月前
已完结
Neutrophil‐to‐lymphocyte ratio (NLR) at diagnosis in essential thrombocythemia: A new promising predictor of thrombotic events
4个月前
已完结
Dual PI3K/mTOR inhibition shows antileukemic activity in MLL-rearranged acute myeloid leukemia
5个月前
已完结
The potential underlying mechanism of the leukemia caused by MLL-fusion and potential treatments
5个月前
已完结
HOXA9 Regulome and Pharmacological Interventions in Leukemia
5个月前
已完结
Nucleoside and Non-Nucleoside DOT1L Inhibitors: Dawn of MLLrearranged Leukemia
5个月前
已完结
The molecular functions of common and atypical MLL fusion protein complexes
5个月前
已完结
皖公网安备34019202002308
